Skip to main content

Table 3 Characteristics of selected E. cloacae isolates

From: Dynamics of colistin and tobramycin resistance among Enterobacter cloacae during prolonged use of selective decontamination of the digestive tract

Cluster

Number of isolates

Location of patients located in hospital 1 or 2 at time of culture

Period of detection

Resistance (n/n tested)

Colistin

Tobramycin

ESBL

A

49

Intensive care unit (34 patients ICU 1; 5 patients ICU 2)

June 2009 – May 2014

non-S (46/47)

non-S (46/47)

positive (41/45)

B

38

Intensive care unit (29 patients ICU 1; 5 patients ICU 2)

December 2009 – August 2014

non-S (37/38)

non-S (38/38)

positive (31/33)

C

3

Ward (2 patients hospital 1; 1 patient hospital 2)

June 2013 – February 2014

S (3/3)

S (3/3)

negative (2/3)

D

5

Intensive care unit (3 patients ICU 1)

September 2009 – May 2012

S (4/4)

S (4/4)

positive (4/4)

E

3

Ward (1 patient hospital 1)

January 2014 – January 2014

S (1/1)

S (1/1)

positive (1/1)

F

2

Ward/outpatient (2 patients hospital 1)

July 2013 – August 2014

S (2/2)

S (2/2)

negative (2/2)

G

2

Ward (1 patient hospital 1)

February 2012 – April 2012

S (2/2)

S (2/2)

positive (1/2)

H

19

Intensive care unit (6 patients hospital 1), ward (5 patients hospital 1)

April 2010 – July 2014

S (13/14)

non-S (13/14)

positive (7/14)

  1. ESBL extended-spectrum beta-lactamase, ICU intensive care unit, n number, non-S non-susceptible, S susceptible